Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Takes Charges of $51.7M for Headcount Reductions

NEW YORK(GenomeWeb) – Hologic said in a regulatory filing that it took charges to its financials of $51.7 million for Fiscal Year 2014, primarily for headcount reductions.

In a Form 10-K filed on Thursday with the US Securities and Exchange Commission, the company said that the charges were related to several steps it took in order to save costs, including cost-containment steps implemented in Q1 FY 2014 that resulted in layoffs. Additionally, in the second, third, and fourth quarters, Hologic terminated some employees at its HiTec Imaging operation in Germany and terminated certain executives and employees on a worldwide basis.

In 2013, the firm recorded a $32.8 million charge related to similar actions, it said.

Earlier this month, Hologic said that its revenues for FY 2014, which ended on Sept. 27, were up almost 2 percent to $2.53 billion.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.